
Cheryl Reicin
Cheryl Reicin is a partner and international chair of life sciences at Mintz LLP, known for her expertise in the pharmaceutical industry. She has recently been in the news discussing the uncertainties surrounding potential U.S. tariffs and pricing rules that could significantly impact drug manufacturers.
Power1,507
Reach33,693
Country presence
Recent news mentions
Cheryl Reicin is a partner and co-chair of life sciences with law firm Mintz, Levin, Cohn, Ferris, Glovsky and Popeo PC.
Has Canada’s biotech moment finally arrived?The Globe and Mail·
Canada· 2026-08-04
Cheryl Reicin, partner and international chair of life sciences at Mintz LLP, expressed that her clients are not making any decisions yet due to uncertainty.
Potential U.S. tariffs, pricing rules raise uncertainty in drug industryThe Globe and Mail·
Canada· 2025-07-11












